MannKind Newsroom

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Hims & Hers Health (HIMS) and MannKind (MNKD)

TipRanksNov 6 16:10 · Ratings

MannKind to Present at 2024 UBS Healthcare Conference

GlobeNewswireNov 6 05:15

Express News | MannKind Corp - No Serious Adverse Events or Study Drug Discontinuation

BreakingsNov 4 19:05

Express News | MannKind Corp - Expects FDA Meeting in 1H 2025 to Advance Mnkd-201

BreakingsNov 4 19:05

Express News | MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases

BreakingsNov 4 19:05

Earnings Preview: MannKind to Report Financial Results Post-market on November 07

$MannKind(MNKD.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $MannKind(MNKD.US)$ to post revenue of USD74.49M for 2024Q3, up 45.33

Futu NewsNov 2 09:00

MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024

GlobeNewswireNov 1 04:05

Express News | First Site Initiated in Australia for Mannkind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (Ntm) Lung Disease

BreakingsOct 31 09:00

Even Though MannKind (NASDAQ:MNKD) Has Lost US$66m Market Cap in Last 7 Days, Shareholders Are Still up 392% Over 5 Years

Simply Wall StOct 24 21:07

MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ...

InvestingOct 9 23:13

Why MannKind (MNKD) Could Beat Earnings Estimates Again

Zacks Oct 7 23:15

MannKind (MNKD) Just Overtook the 20-Day Moving Average

Zacks Oct 4 20:40

MannKind Reports 30-week Results From Phase 4 INHALE-3 Study - Quick Facts

RTTNewsSep 30 18:09

Express News | MannKind Corp: Look Forward to Discussing More Details of 30-Week Study Results at Conferences in 2025

BreakingsSep 30 18:05

Express News | MannKind Corp: Announced Top-Level 30-Week Results From Its Phase 4 Inhale-3 Study

BreakingsSep 30 18:04

MannKind's Afrezza Demonstrates A1c Control In Diabetes Patients During MannKind's Phase 4 Trial

BenzingaSep 30 18:04

More Adults With Type 1 Diabetes Achieved A1C Goal (

GlobeNewswireSep 30 18:00

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaSep 24 01:35

MannKind Corporation (MNKD): Short Seller Sentiment Is Bearish

Yahoo FinanceSep 21 14:47

Exchange-Traded Funds, Equity Futures Slightly Higher Pre-Bell as Investors Weigh Fed Rate Cut

MT NewswiresSep 18 20:25